CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Axiron Topical Solution

perrigo

Perrigo Gets Patent Challenge For Generic Axiron, FDA Approval For Generic Sanctura XR

Perrigo Co. (Nasdaq: PRGO) announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for testosterone topical solution, the generic version of Axiron Topical Solution.

WWJ Newsradio 950–05/29/2013

Follow

Get every new post delivered to your Inbox.

Join 1,884 other followers